ir.recursion.com Open in urlscan Pro
2606:4700::6811:ce9f  Public Scan

Form analysis
0 forms found in the DOM

Text Content

 * Investors
 * Governance
   Board of Directors Governance Documents Executive Leadership
 * News
 * SEC Filings
 * Stock
   Interactive Chart Analyst Coverage
 * Resources
   Materials Events Alerts Contacts
 * ESG


THE INDUSTRIAL REVOLUTION OF DRUG DISCOVERY IS HERE.





Recursion is a clinical-stage biotechnology company decoding biology to
radically improve lives by industrializing drug discovery, development and
beyond through disruptive innovation.

View our most recent corporate materials.


Recent News
Alerts
Dec 20, 2022
Recursion to Participate in Upcoming Investor Conferences

Recursion (NASDAQ: RXRX), the clinical-stage biotechnology company
industrializing drug discovery by decoding biology, today announced its
participation in the following investor conferences: 41st...

Nov 8, 2022
 * 

Recursion Provides Business Updates and Reports Third Quarter 2022 Financial
Results

Initiated our Phase 2 clinical trial for the potential treatment of familial
adenomatous polyposis (FAP) Initiated our Phase 1 clinical trial for the
potential treatment of Clostridium difficile...

Nov 2, 2022
Recursion to Participate in Upcoming Investor Conferences

Recursion (NASDAQ: RXRX), the clinical-stage biotechnology company
industrializing drug discovery by decoding biology, today announced its
participation in the following investor conferences:...

Stock Info
NASDAQRXRX
$7.51
Last Price
-$0.12
(-1.57%)
Change
1.1M
Volume
$1.4B
Market Cap
Currency in USD.
Quote data delayed by at least 15 minutes.
Stay up to date on the latest news and events from Recursion.

 

Subscribe here

Investor Contact

Investor@Recursion.com